Suncare Traders Ltd

Suncare Traders Ltd has submitted its Annual Report for the financial year 2025-26, along with the Notice of its 29th Annual General Meeting (AGM). The AGM is scheduled for Tuesday, September 29, 2026, at the company's registered office in Ahmedabad. Key agenda items include the adoption of audited financial statements for FY26 and the appointment of Mr. Ramesh Salvi as Whole Time Director & CFO for a period of 3 years on nil remuneration. The report also details the corporate information, board of directors, committees, and key managerial personnel.

Suncare Traders Ltd has issued a notice for its 29th Annual General Meeting (AGM) to be held on Tuesday, September 29, 2026, at its registered office in Ahmedabad. The meeting will transact ordinary business, including the adoption of audited financial statements for the fiscal year ended March 31, 2026. Special business includes the proposed appointment of Mr. Ramesh Salvi as Whole Time Director and Chief Financial Officer (CFO) for a period of 3 years, effective July 21, 2026, on nil remuneration. The notice also details procedures for proxy appointments, electronic voting, and the closure of the Register of Members from September 22 to September 29, 2026.

Suncare Traders Ltd has filed a statement regarding the utilization of proceeds from past public issues, rights issues, preferential issues, or QIPs. The company confirms that as of June 30, 2026, and as of the current date, there are no remaining unutilized funds from any such past issuances. Consequently, no further information or annexure is being provided as per SEBI regulations.

Suncare Traders Ltd announced that its Board of Directors, in a meeting held on August 7, 2026, considered and approved the un-audited financial results for the quarter ended June 30, 2026. The meeting commenced at 03:10 PM and concluded at 03:30 PM. The financial results were reviewed by the Audit Committee and have undergone a limited review by the Statutory Auditors. The company operates in a single segment.

Suncare Traders Ltd announced that its Board of Directors, in a meeting held on August 7, 2026, approved the un-audited financial results for the quarter ended June 30, 2026. The board meeting commenced at 3:10 PM and concluded at 3:30 PM. The financial results were reviewed by the Audit Committee and have undergone a limited review by the statutory auditors. The company operates in a single segment.

Suncare Traders Ltd announced key management changes following a board meeting. Mr. Ramesh Salvi has been appointed as Whole-time Director and Chief Financial Officer, effective July 21, 2026, subject to shareholder approval. Concurrently, Mr. Harshad Rathod has resigned from his positions as Whole-time Director and Chief Financial Officer, also effective July 21, 2026, citing personal commitments. Mr. Salvi, 32, brings 5 years of experience in accounts and finance. The board meeting was brief, lasting from 3:15 PM to 3:30 PM.

Shree Ganesh Bio-Tech (India) Limited has disclosed a sale of 86,48,166 equity shares, representing 3.39% of the total voting capital, in Suncare Traders Limited. This transaction occurred between April 1, 2026, and June 22, 2026, via open market operations. Following the sale, Shree Ganesh Bio-Tech's holding in Suncare Traders has reduced from 5.28% (1,34,58,166 shares) to 1.89% (48,10,000 shares). The total equity share capital of Suncare Traders remains ₹51,00,00,000, divided into 25,50,00,000 equity shares of ₹2 each.

Suncare Traders Ltd has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Wednesday, July 1, 2026, and will continue until 48 hours after the declaration of the unaudited financial results for the first quarter ended June 30, 2026. The specific date for the board meeting to approve these results will be communicated later. This measure is in compliance with SEBI regulations and the company's internal code of conduct for preventing insider trading.

Suncare Traders Ltd. has announced that as of March 31, 2026, and the current date, it has no remaining unutilized funds from any public issue, rights issue, preferential issue, or qualified institutional placement (QIP) undertaken in the past. Consequently, the company will not be providing Annexure-A as per Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and SEBI Circular CIR/CFD/CMD1/162/2019 dated December 24, 2019.

Suncare Traders Ltd's board approved the audited financial results for the year ended March 31, 2026. The company reported a total income from operations of ₹251.74 lakhs and a net profit after tax of ₹66.21 lakhs. The auditor's report issued an unmodified opinion. The board meeting concluded on May 7, 2026.